Search Results - Mustafa Erman
- Showing 1 - 20 results of 23
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
Smoker Relatives of Inpatients: A Reasonable but Heterogeneous Target Population for Smoking Cessation Program by Burak Yasin Aktaş, Beril Hüseyin, Deniz Yüce, Ömer Dizdar, Mustafa Erman, Mutlu Hayran, İsmail Çelik
Published in Archives of Basic and Clinical Research (2023-01-01)Get full text
Article -
6
Baseline and three-month De Ritis ratio and gamma-glutamyltransferase as prognostic biomarkers in metastatic renal cell carcinoma treated with targeted therapy by Oktay Halit Aktepe, Tugce Ulasli, Ilkay Tugba Unek, Elif Atag, Huseyin Salih Semiz, Aziz Karaoglu, Mustafa Erman, Suayib Yalcin
Published in Scientific Reports (2026-03-01)Get full text
Article -
7
Prognostic Nutritional Index and a Blood-Based Prognostic Tool in Prostate Cancer Treated with Abiraterone, Enzalutamide or Cabazitaxel by Hakan Taban, Mustafa Erman, Deniz Can Guven, Burak Yasin Aktas, Feride Yilmaz, Serkan Yaşar, Hasan Cagri Yildirim, Ferit Aslan, Sercan Aksoy
Published in Medicina (2025-06-01)Get full text
Article -
8
-
9
Mean Platelet Volume to Lymphocyte Ratio: A New Biomarker Predicting Response in Patients with Solid Tumors Treated with Nivolumab by Hasan Cagri Yildirim, Fatih Kus, Deniz Can Guven, Ece Karaca, Yunus Kaygusuz, Omer Dizdar, Sercan Aksoy, Mustafa Erman, Suayib Yalcin, Saadettin Kilickap
Published in Journal of Immunotherapy and Precision Oncology (2023-11-01)Get full text
Article -
10
Baseline serum folic acid as a prognostic biomarker in metastatic renal cell carcinoma treated with targeted therapy by Oktay Halit Aktepe, Rezan Berkay Izgor, Tugce Ulasli, Ilkay Tugba Unek, Elif Atag, Huseyin Salih Semiz, Aziz Karaoglu, Mustafa Erman, Suayib Yalcin
Published in Discover Oncology (2026-03-01)Get full text
Article -
11
Total cholesterol/high-density lipoprotein cholesterol ratio is a candidate predictor of survival outcomes in patients with metastatic renal cell carcinoma by Oktay Halit Aktepe, Ozge Yetginoglu, Mehmet Sinan Akarca, Canberk Sencan, Ahmet Unal, Elif Atag, Huseyin Salih Semiz, Aziz Karaoglu, Mustafa Erman, Suayib Yalcin
Published in Scientific Reports (2025-06-01)Get full text
Article -
12
Bi-weekly irinotecan is an effective and convenient regimen in the treatment of relapsed or refractory small cell lung cancer by Feride Yılmaz, Serkan Yaşar, Ömer Denizhan Tatar, Hasan Çağrı Yıldırım, Deniz Can Güven, Arif Akyıldız, Elvin Chalabiyev, Burak Yasin Aktaş, Zafer Arık, Mustafa Erman
Published in BMC Cancer (2024-10-01)Get full text
Article -
13
Association Between Baseline and Changes in Early Neutrophil-to-Lymphocyte Ratio on Survival in Patients with Metastatic Bladder Carcinoma Treated with Immunotherapy by Ezgi Değerli, Çağatay Arslan, Fatih Selçukbiricik, Ömer Fatih Ölmez, Dilek Erdem, Jamshid Hamdard, Mesut Yılmaz, Rumeysa Çolak, Caner Kapar, Mustafa Erman, Fatih Kuş, Deniz Tural
Published in Medicina (2024-12-01)Get full text
Article -
14
Impact of Adipokine Expression on Tumor Characteristics and Survival Outcomes in Patients with Renal Cell Carcinoma by Oktay Halit Aktepe, Tugce Ulasli, Aytac Terzi, Fatma Gundogdu, Eda Caliskan Yildirim, Ahmet Melih Arslan, Huseyin Salih Semiz, Kemal Kosemehmetoglu, Aziz Karaoglu, Mustafa Erman, Suayib Yalcin
Published in Medicina (2025-08-01)Get full text
Article -
15
459 Phase 3 study of first-line pembrolizumab with and without vibostolimab (anti-TIGIT) in patients with PD-L1–positive metastatic NSCLC by Matthew Hellmann, Ying Cheng, Toshiaki Takahashi, Gilberto de Castro, M Catherine Pietanza, James Chih-Hsin Yang, Byoung Cho, Rosalyn Juergens, Mustafa Erman, Jessica Bauman, Paul Schwarzenberger, Pingye Zhang
Published in Journal for ImmunoTherapy of Cancer (2021-11-01)Article -
16
Real-world testing practices, treatment patterns, and outcomes of tyrosine kinase inhibitors (TKIs) in epidermal growth factor receptor-mutated advanced/metastatic non-small cell l... by Jens Samol, Ingel Demedts, Mustafa Erman, Vadim Kozlov, Jose N Minatta, Fedor Moiseenko, Michael Mark, Senthil Rajappa, Tom Bailey, Hannah Wallis, Leslie Servidio, Doreen A Kahangire, Mauro Zukin
Published in Cancer Treatment and Research Communications (2026-01-01)Get full text
Article -
17
Correction to: Prospective observational study on Pazopanib in patients treated for advanced or metastatic renal cell carcinoma in countries in Asia Pacific, North Africa, and Midd... by Mustafa Erman, Bivas Biswas, Pongwut Danchaivijitr, Lingwu Chen, Yoke Fui Wong, Tarek Hashem, Chun Sen Lim, Bulent Karabulut, Hsiao-Jen Chung, Chandrasekhar Chikatapu, Sara Ingles, Khemaies Slimane, Ravindran Kanesvaran
Published in BMC Cancer (2021-11-01)Get full text
Article -
18
Prognostic Impact of Glomerular Filtration Rate Decline on Survival Outcomes in Metastatic Renal Cell Carcinoma Treated with Targeted Therapy by Oktay Halit Aktepe, Ahmet Melih Arslan, Ozge Yetginoglu, Hatice Altas, Canberk Sencan, Mehmet Sinan Akarca, Hasan Cagri Yildirim, Huseyin Salih Semiz, Ilkay Tugba Unek, Aziz Karaoglu, Mustafa Erman, Suayib Yalcin
Published in Medicina (2025-08-01)Get full text
Article -
19
Efficacy and Clinical Outcomes of Crizotinib in Patients with ROS1-Rearranged NSCLC: A Multicenter Study by Alper Topal, Goncagul Akdag, Sedat Yildirim, Oguzcan Kinikoglu, Deniz Isik, Gizem Yildirim, Salih Tunbekici, Fatih Kus, Aydın Acarbay, Murad Guliyev, Nargiz Majidova, Yasin Kutlu, Mustafa Erman, Hatice Odabas, Nedim Turan, Nuri Karadurmus
Published in Medicina (2025-03-01)Get full text
Article -
20
The efficacy of immunotherapy and chemoimmunotherapy in patients with advanced rare tumors: A Turkish oncology group (TOG) study by Deniz Can Guven, Musa Baris Aykan, Harun Muglu, Ertugrul Bayram, Kaan Helvaci, Bengü Dursun, Melisa Celayir, Elvin Chelebiyev, Erdinc Nayir, Mustafa Erman, Ahmet Sezer, Yuksel Urun, Umut Demirci, Ozlem Er, Umut Disel, Ahmet Bilici, Cagatay Arslan, Nuri Karadurmus, Saadettin Kilickap
Published in Cancer Medicine (2024-01-01)Get full text
Article